You are here: Industry Insights > COVID-19

News List

New study finds AstraZeneca booster generates higher antibodies against Omicron pharmatimes
January 13, 2022
AstraZeneca (AZ) has reported preliminary data from a trial it conducted on its COVID-19 booster shot, Vaxzevria.
Ardena Expands Capacity to Satisfy Novavax COVID Vaccine Demand contractpharma
January 13, 2022
Site in Södertälje, Sweden will see capacity increases in purification and fractionation of GMP manufacturing.
U.S. May Soon See Sharp Drop in Omicron Cases, Experts Say drugs.com
January 12, 2022
The omicron surge may have peaked in Britain and could be about to do the same in the United States, experts report.
Nearly 600,000 U.S. Children Had COVID-19 Last Week drugs.com
January 12, 2022
In a sign that the highly contagious omicron variant is sparing no one, a report shows that new COVID-19 cases among U.S. children...
South Korea Approves Novavax COVID-19 Vaccine contractpharma
January 12, 2022
Nuvaxovid is the first protein-based COVID-19 vaccine granted approval in South Korea.
UKHSA estimates one in seven still infectious after five day COVID-19 isolation pharmatimes
January 12, 2022
Under current guidelines, individuals that test positive for COVID-19 may be able to leave self-isolation after 7 days if certain conditions are met.
BinaxNOW Test Catches COVID-19 Infection in Many People, Study Shows drugs.com
January 12, 2022
Countering earlier concerns, a real-world study shows that a widely used at-home COVID-19 test called BinaxNOW is as effective at detecting omicron as other coronavirus variants.
Keep Your Home Safe and Build a Protected Community Against Omicron with Circle HealthPod prnasia
January 11, 2022
With an increasing number of confirmed cases in Hong Kong, S.A.R., China, S.A.R., China since the initial transmission on 27th December 2021, the recent Omicron outbreak is of utmost concern in the community.
MGI Aims to Boost its Market Share through Participation at Expo 2020 Dubai's Guangdong Week prnasia
January 11, 2022
Global life science innovator MGI Tech Co. Ltd. (MGI) is aiming to boost its market share in the Middle East and Asia through participation at Guangdong Week, a dedicated event taking place at the world exhibition's China Pavilion from January 11-13.
Omicron wave disrupts wage growth hopes in Australia – leading macroeconomic influencers Pharmaceutical-Technology
January 11, 2022
Some economists believe that the Omicron wave will be a clear risk to pay rises this year, as increasing case numbers threaten to disrupt Australia’s economic recovery.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page